SCHEMBL628314

SCHEMBL628314

O=C(O)C[C@H]1CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL628315 1.00
SCHEMBL1691652 1.00
SCHEMBL2201489 0.87 SLC6A12 (0.39)
SCHEMBL12080316 0.87 SLC6A12 (0.39)
SCHEMBL12081534 0.87 SLC6A12 (0.39)
SCHEMBL16037148 0.86 SLC6A12 (0.40)
SCHEMBL304222 0.86 SLC6A12 (0.45)
SCHEMBL27699620 0.85 SLC6A1 (0.38)
SCHEMBL27720295 0.82 SLC6A12 (0.36)
SCHEMBL1830399 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114806414-B Silicon polishing composition, preparation method and application thereof 万华化学集团电子材料有限公司 2023-07-11 CN claimed
CN-114806414-A Silicon polishing composition, preparation method and application thereof 万华化学集团电子材料有限公司 2022-07-29 CN claimed
CN-114806414-B Silicon polishing composition, preparation method and application thereof 万华化学集团电子材料有限公司 2023-07-11 CN disclosed
CN-114806414-A Silicon polishing composition, preparation method and application thereof 万华化学集团电子材料有限公司 2022-07-29 CN disclosed
US-20140194349-A1 HIV Protease Inhibiting Compounds ABBVIE INC. (US) 2014-07-10 US disclosed
EP-2342199-B1 Sulfonyl compounds which selectively modulate the CB2 receptor BOEHRINGER INGELHEIM INT (DE) 2014-02-26 EP disclosed
EP-2542539-B1 TETRAZOLE COMPOUNDS WHICH SELECTIVELY MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INT (DE) 2014-02-26 EP disclosed
US-8372874-B2 Compounds which selectively modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-02-12 US disclosed
US-8372874-B2 Compounds which selectively modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-02-12 US disclosed
US-8372874-B2 Compounds which selectively modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-02-12 US disclosed
US-8362039-B2 Therapeutic uses of compounds which selectively modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-29 US disclosed
EP-2125792-A1 PURINE DERIVATIVES AS IMMUNOMODULATORS Smithkline Beecham Corporation (US) 2009-12-02 EP disclosed
US-20090131458-A1 Compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-05-21 US disclosed
US-20080227132-A1 Hydrolase Enzymes and Their Use in Kinetic Resolution VERENIUM CORPORATION ( FORMERLY DIVERSA CORPORATION ) (US) 2008-09-18 US disclosed
WO-2008101867-A1 PURINE DERIVATIVES AS IMMUNOMODULATORS SMITHKLINE BEECHAM CORPORATION (US) 2008-08-28 WO disclosed
EP-1697344-A2 HIV PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 2006-09-06 EP disclosed
US-20050148623-A1 Prevent reproduct of aids virus ABBVIE INC. 2005-07-07 US disclosed
WO-2005058841-A2 HIV PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 2005-06-30 WO disclosed
US-20050123991-A1 Nucleotide sequences coding hydrolase capable of resolving enantiomeric mixtures of alcohol or ester substrates; for use in regio-and stereoselective biotransformations VERENIUM CORPORATION 2005-06-09 US disclosed
US-20020137171-A1 Hydrolase enzymes and their use in kinetic resolution DIVERSA CORPORATION 2002-09-26 US disclosed